Oral semaglutide lowers risk of heart failure events in people with Type 2 diabetes
February 26, 2026
February 26, 2026
PORTLAND, Oregon, Feb. 26 -- Oregon Health and Science University issued the following news:
* * *
Oral semaglutide lowers risk of heart failure events in people with Type 2 diabetes
*
An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with Type 2 diabetes who already had heart failure.
The findings, published in JAMA I . . .
* * *
Oral semaglutide lowers risk of heart failure events in people with Type 2 diabetes
*
An international clinical trial has found that an oral form of semaglutide, a widely used diabetes drug, reduced the risk of serious heart failure events in people with Type 2 diabetes who already had heart failure.
The findings, published in JAMA I . . .